Maravai Lifesciences Holdings (MRVI) Divestments (2021)

Maravai Lifesciences Holdings (MRVI) recorded quarterly Divestments of $120.7 million in Q3 2021.

Maravai Lifesciences Holdings (MRVI) Divestments (2021) Analysis & Trends

Maravai Lifesciences Holdings' Divestments history runs 1 years deep, the most recent figure standing at $120.7 million for Q3 2021.

  • In Q3 2021, Divestments changed N/A year-over-year to $120.7 million; the TTM figure through Dec 2023 stood at $120.7 million (changed N/A YoY), while the FY2022 annual figure was $620000.0, down 99.48% from the prior year.
  • Divestments was $120.7 million for Q3 2021 at Maravai Lifesciences Holdings.
  • In the past five years, Divestments ranged from a high of $120.7 million in Q3 2021 to a low of $120.7 million in Q3 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Divestments (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - -
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - -
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - -
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -
7 Psyence Biomedical 251.43 Bn 251.42 Bn - -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn -
9 Abivax 94.37 Bn 94.37 Bn - -
10 Maravai Lifesciences Holdings 737.25 Mn 728.85 Mn 33.70 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2021 120.70 Mn